Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in Cardiac Arrest
NCT04134078Phase 1Unknown
- Sponsor
- Stony Brook University
- Start
- Aug 2016
- Primary completion
- Jul 2020
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nitric oxide in cardiac arrest (SCA), sponsored by Stony Brook University. Primary endpoints: Return of Spontaneous Circulation at 1 day and Cerebral Oxygenation at 1 day. Status: unknown.
02
Drugs
nitric oxide
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT04134078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134078.